Invention Grant
US07935333B2 Method and compositions for modifying target receptor function associated with neurological disorders
失效
用于修饰与神经系统疾病相关的靶受体功能的方法和组合物
- Patent Title: Method and compositions for modifying target receptor function associated with neurological disorders
- Patent Title (中): 用于修饰与神经系统疾病相关的靶受体功能的方法和组合物
-
Application No.: US10776780Application Date: 2004-02-10
-
Publication No.: US07935333B2Publication Date: 2011-05-03
- Inventor: Matthew J. During
- Applicant: Matthew J. During
- Applicant Address: NZ Wellington
- Assignee: Auckland Technology Enabling Corporation
- Current Assignee: Auckland Technology Enabling Corporation
- Current Assignee Address: NZ Wellington
- Agency: Nutter McClennen & Fish LLP
- Agent Thomas J. Engellenner
- Main IPC: A01N63/00
- IPC: A01N63/00 ; A01N65/00 ; A61K48/00 ; C12N15/00
Abstract:
A method of treating or preventing development of a neurological disorder has been developed wherein a subject with the disorder, or at risk of developing a disorder, is vaccinated against a brain protein or antigen. Alternatively, the antibodies can be directly administered to the individual in need of treatment thereof. Animal studies demonstrate potent efficacy in the treatment of epilepsy, stroke and cognition in animal models vaccinated against the NMDA receptor.
Public/Granted literature
- US20040131596A1 Method and compositions for modifying target receptor function associated with neurological disorders Public/Granted day:2004-07-08
Information query
